QPI Allows in vitro Drug Screening of Triple Negative Breast Cancer PDX Tumors and Fine Needle Biopsies

QPI Allows in vitro Drug Screening of Triple Negative Breast Cancer PDX Tumors and Fine Needle Biopsies

The development of resistance to initially successful cancer therapies is a major cause of the morbidity and mortality associated with cancer. Identifying evolving resistance at an early stage could inform clinical decision making to adapt therapies before resistant cancer cell phenotypes have becom...

Full description

Bibliographic Details
Main Authors: Graeme F. Murray, Tia H. Turner, Daniel Guest, Kevin A. Leslie, Mohammad A. Alzubi, Senthil K. Radhakrishnan, J. Chuck Harrell, Jason Reed
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Physics
Subjects:
quantitative phase imaging
personalized medicine
fine needle biopsy
patient derived xenografts
breast cancer
high speed live cell interferometry
Online Access:https://www.frontiersin.org/article/10.3389/fphy.2019.00158/full

Internet

https://www.frontiersin.org/article/10.3389/fphy.2019.00158/full

Similar Items